A Clinical Trial of MT200605 for the Treatment of Acute Ischemic Stroke
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 360 participants.
Also called NCT07205328
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 360 participants
- Sponsor
- Shaanxi Micot Pharmaceutical Technology Co., Ltd.
- Registry
-
NCT07205328
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT07205328. Randomized; quadruple masking; primary purpose treatment. Start 2025-09-30 (actual); primary completion 2026-06-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Clinical Trial of MT200605 for the Treatment of Acute Ischemic Stroke
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- MT200605
- Intervention (Drug)
- MT200605
- Intervention (Drug)
- MT200605
- Intervention (Drug)
- Placebo
- Lead sponsor
- Shaanxi Micot Pharmaceutical Technology Co., Ltd.
Record details
- Record id
cardio:ct-nct07205328- Content hash
b193f4beb7586626dcc99520344dcda83930d8cb5da993f0e7be8182c5162ecd